Verona Pharma plc

DB:I9SA 주식 보고서

시가총액: €3.0b

Verona Pharma 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?


최근 내부자 거래

DB:I9SA 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
18 Nov 24Buy€31,505David EbsworthIndividual2,500€12.60
11 Nov 24Sell€11,267Mark HahnIndividual300€37.56
11 Nov 24Sell€11,267David ZaccardelliIndividual300€37.56
06 Nov 24Buy€184,856Christina AckermannIndividual5,235€35.31
06 Nov 24Buy€175,999David EbsworthIndividual4,920€35.77
04 Nov 24Sell€522,063Mark HahnIndividual16,209€32.24
04 Nov 24Sell€568,237David ZaccardelliIndividual17,629€32.27
25 Oct 24Sell€585,720David ZaccardelliIndividual18,102€32.36
25 Oct 24Sell€584,671Mark HahnIndividual18,070€32.36
22 Oct 24Sell€2,130,529Mark HahnIndividual525,768€4.06
22 Oct 24Sell€2,083,793David ZaccardelliIndividual514,152€4.06
11 Sep 24Sell€2,047,155Mark HahnIndividual600,000€3.41
11 Sep 24Sell€2,047,373David ZaccardelliIndividual600,000€3.41
13 Aug 24Sell€1,164,441Mark HahnIndividual49,800€23.74
12 Aug 24Buy€94,486David EbsworthIndividual4,500€21.00
12 Aug 24Sell€4,580Mark HahnIndividual200€22.90
12 Aug 24Sell€4,580David ZaccardelliIndividual200€22.90

내부자 거래량

내부자 구매: I9SA insiders는 지난 3개월 동안 구매한 것보다 더 많은 주식을 판매했습니다.


소유권 분석

I9SA 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
일반 대중2,424,1652.96%
개인 내부자3,660,3714.47%
헤지 펀드4,215,9735.15%
VC/PE 기업18,096,32522.1%
교육기관53,434,33565.3%

주식의 희석: 지난 해 주주들은 의미 있게 희석되지 않았습니다.


최대 주주

상위 25 주주가 회사의 74.81%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
7.72%
Perceptive Advisors LLC
6,315,933€234.1m160%4.93%
7.57%
RA Capital Management, L.P.
6,195,639€229.6m-29.7%2.72%
6.82%
New Enterprise Associates, Inc.
5,584,753€207.0m0%9.11%
5.15%
Maverick Capital, Ltd.
4,215,973€156.3m36.3%2.78%
4.62%
OrbiMed Advisors LLC
3,777,778€140.0m0%1.88%
4.34%
Vivo Capital, LLC
3,549,779€131.6m-46.3%10.76%
4.14%
Frazier Life Sciences Management, LP
3,383,950€125.4m2.1%4.86%
3.89%
Deep Track Capital, LP
3,180,025€117.9m-20.5%3.52%
2.96%
Eventide Asset Management, LLC
2,425,846€89.9m360%1.51%
2.65%
Federated Hermes, Inc.
2,167,900€80.3m0.2%0.19%
2.3%
Wellington Management Group LLP
1,878,632€69.6m19.6%0.01%
2.24%
Octagon Capital Advisors LP
1,835,200€68.0m-3.17%10.86%
2.13%
Jennison Associates LLC
1,740,886€64.5m54.3%0.04%
1.86%
David Zaccardelli
1,525,294€56.5m-1.8%데이터 없음
1.76%
Caligan Partners, LP
1,436,878€53.3m-22.1%16.15%
1.75%
Hood River Capital Management LLC
1,433,934€53.1m35%0.78%
1.72%
Mark Hahn
1,411,417€52.3m-1.94%데이터 없음
1.63%
T. Rowe Price Group, Inc.
1,335,194€49.5m40.6%데이터 없음
1.49%
Bellevue Asset Management AG
1,220,059€45.2m7.57%0.52%
1.44%
Citadel Advisors LLC
1,178,022€43.7m1,050%0.05%
1.43%
Federated Equity Management Company of Pennsylvania
1,173,600€43.5m0%0.23%
1.36%
Aisling Capital Management LP
1,115,352€41.3m0%15.85%
1.36%
Loomis Sayles & Company, L.P.
1,111,096€41.2m0%0.05%
1.27%
Janus Henderson Group plc
1,042,795€38.6m-4.51%0.01%
1.2%
Rice Hall James & Associates, LLC
985,076€36.5m4.84%1.9%